13D Filing: Starboard Value LP and Depomed Inc (DEPO)

Page 16 of 23

Page 16 of 23 – SEC Filing

B. Starboard S LLC
(a) As of the close of business on April 5, 2018, Starboard S LLC beneficially owned 430,843 Shares.

Percentage: Less than 1%

(b) 1. Sole power to vote or direct vote: 430,843
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 430,843
4. Shared power to dispose or direct the disposition: 0
(c) The transactions in the Shares by Starboard S LLC since the filing of Amendment No. 8 to the Schedule
13D are set forth in Schedule A and are incorporated herein by reference.
C. Starboard C LP
(a) As of the close of business on April 5, 2018, Starboard C LP beneficially owned 239,310 Shares.

Percentage: Less than 1%

(b) 1. Sole power to vote or direct vote: 239,310
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 239,310
4. Shared power to dispose or direct the disposition: 0
(c) The transactions in the Shares by Starboard C LP since the filing of Amendment No. 8 to the Schedule
13D are set forth in Schedule A and are incorporated herein by reference.
D. Starboard R LP
(a) Starboard R LP, as the general partner of Starboard C LP, may be deemed the beneficial owner of
the 239,310 shares owned by Starboard C LP.

Percentage: Less than 1%

(b) 1. Sole power to vote or direct vote: 239,310
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 239,310
4. Shared power to dispose or direct the disposition: 0
(c) Starboard R LP has not entered into any transactions in the Shares since the filing of Amendment
No. 8 to the Schedule 13D. The transactions in the Shares on behalf of Starboard C LP since the filing of Amendment No. 8 to the
Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
E. Starboard R GP
(a) Starboard R GP, as the general partner of Starboard R LP, may be deemed the beneficial owner of
the 239,310 shares owned by Starboard C LP.

Percentage: Less than 1%

16

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Page 16 of 23